Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-21-000280
Filing Date
2021-02-16
Accepted
2021-02-16 16:23:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING volitionrx_13gdec312020.htm SC 13G 41615
  Complete submission text file 0000905718-21-000280.txt   43278
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Subject) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-78472 | Film No.: 21638972
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 3 COLUMBUS CIRCLE SUITE 2215 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE SUITE 2215 NEW YORK NY 10019 212-309-7664
Lagoda Investment Management, L.P. (Filed by) CIK: 0001632108 (see all company filings)

EIN.: 464740139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G